Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Jeremy M. Levin, D.Phil.$227M
Market Cap • 18/04/20242014
(há 10 anos)
2017
(7 years ago)
NASDAQ
Listagem
New York
Sede • New York44
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
OVIDSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.